Discussing the Regulatory Perspective for Comparability in Gene Therapy Analytical Development
Time: 8:30 am
day: Conference Day Two
- Addressing the additional challenges in comparability specific to gene therapies
- Ensuring comparability and dosing strategies keep up with changing instrumentation and non-direct comparable results
- How do assays needed for comparability studies alter as gene therapies enter later phase development?